Department of Neurology, Danish Headache Center, Rigshospitalet, Glostrup, Denmark.
Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.
Cephalalgia. 2020 Oct;40(12):1310-1320. doi: 10.1177/0333102420937724. Epub 2020 Jul 1.
The Transient Receptor Potential Ankyrin 1 (TRPA1) channel might play a role in migraine. However, different mechanisms for this have been suggested. The purpose of our study was to investigate the localization and significance of TRPA1 channels in rat pial and dural arteries.
Immunofluorescence microscopy was used to localize TRPA1 channels in dural arteries, pial arteries, dura mater and trigeminal ganglion. The genuine closed cranial window model was used to examine the effect of NaS, a donor of the TRPA1 channel opener HS, on the diameter of pial and dural arteries. Further, we performed blocking experiments with TRPA1 antagonist HC-030031, calcitonin gene-related peptide (CGRP) receptor antagonist olcegepant and K3.1 channel blocker TRAM-34.
TRPA1 channels were localized to the endothelium of both dural and pial arteries and in nerve fibers in dura mater. Further, we found TRPA1 expression in the membrane of trigeminal ganglia neuronal cells, some of them also staining for CGRP. NaS caused dilation of both dural and pial arteries. In dural arteries, this was inhibited by HC-030031 and olcegepant. In pial arteries, the dilation was inhibited by TRAM-34, suggesting involvement of the K3.1 channel.
NaS causes a TRPA1- and CGRP-dependent dilation of dural arteries and a K3.1 channel-dependent dilation of pial arteries in rats.
瞬时受体电位锚蛋白 1(TRPA1)通道可能在偏头痛中发挥作用。然而,已经提出了不同的机制。我们研究的目的是研究 TRPA1 通道在大鼠脑膜和硬脑膜动脉中的定位和意义。
免疫荧光显微镜用于定位硬脑膜动脉、脑膜动脉、硬脑膜和三叉神经节中的 TRPA1 通道。使用真正的封闭颅窗模型来检查 NaS(TRPA1 通道 opener HS 的供体)对脑膜和硬脑膜动脉直径的影响。此外,我们用 TRPA1 拮抗剂 HC-030031、降钙素基因相关肽(CGRP)受体拮抗剂 olcegepant 和 K3.1 通道阻滞剂 TRAM-34 进行阻断实验。
TRPA1 通道定位于硬脑膜和脑膜动脉的内皮以及硬脑膜中的神经纤维中。此外,我们发现 TRPA1 在三叉神经节神经元细胞的膜上表达,其中一些细胞也染色 CGRP。NaS 引起硬脑膜和脑膜动脉扩张。在硬脑膜动脉中,这种扩张被 HC-030031 和 olcegepant 抑制。在脑膜动脉中,扩张被 TRAM-34 抑制,表明 K3.1 通道的参与。
NaS 引起大鼠硬脑膜动脉的 TRPA1 和 CGRP 依赖性扩张以及脑膜动脉的 K3.1 通道依赖性扩张。